Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (KCT0011488) titled 'Cilostazol for prevention of stroke and amelioraation of cerebral perfusion in asymptomatic patients with moyamoya disease' on Jan. 19.

Study Type: Interventional Study

Study Design: Primary Purpose : Other(Exploratory study), Intervention Model : Single Group, Blinding/Masking : Open, Allocation : Not Applicable

Primary Sponsor: Yonsei University Health System, Severance Hospital

Condition:

Diseases of the circulatory system

Intervention: Drug : This is an exploratory study to determine the safety and clinical and radiological efficacy of cilostazol in asymptomatic, first-time diagnosed Moyamoya disease patient...